Reaktionsgleichung
[C:1]([O:4][CH2:5][CH2:6][N+:7]([CH3:10])([CH3:9])[CH3:8])(=[O:3])[CH3:2].[CH:11]1[C:16]([OH:17])=[CH:15][C:14]2[C:18]([CH2:21][CH2:22][NH2:23])=[CH:19][NH:20][C:13]=2[CH:12]=1>>[C:1]([O:4][CH2:5][CH2:6][N+:7]([CH3:10])([CH3:9])[CH3:8])(=[O:3])[CH3:2].[CH:11]1[C:16]([OH:17])=[CH:15][C:14]2[C:18]([CH2:21][CH2:22][NH2:23])=[CH:19][NH:20][C:13]=2[CH:12]=1Komponenten
3
Versuchsvorschrift
Microdialysis studies (resting or challenging conditions) in freely moving, male Sprague Dawley rats (Janvier, 295-315 g, n=5-8/treatment group) were performed using stereotactically instrumented microdialysis probes (CMA/12-14-2): mPFC, hippocampus. Aliquots of the same microdialysate fractions (6 before, and 9-12 after compound administration) were analyzed either for acetylcholine or for serotonin by HPLC and electrochemical detection.
Quellen und Nachweise
- ORD-Eintrag
- ord-39fa8e6160aa4185b6ccd968495161ed
- Quelldatensatz
- uspto-grants-2015_03
- Patentnummer
- US08993632B2
Verknüpfte Notizen
Wird geladen…